ClinicalTrials.gg
Not yet recruitingNCT07156734ACLQuadActUpdated Sep 5, 2025

Effect of Contralateral NMES on Quadriceps Activation After ACL Injury or Surgery

An interventional study of Neuromuscular Electrical Stimulation in ACL Injury, sponsored by Schulthess Klinik. Not yet recruiting. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-09-05.

Sponsored by Schulthess Klinik · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years to 50 Years
Sex
All
01

Study summary

A major complication after cruciate ligament injury and surgery is arthrogenic muscle inhibition of the quadriceps, which is characterised by a deficit in voluntary muscle activation in the affected leg. This can hinder rehabilitation processes, lead to impaired knee function, and negatively impact the patients' quality of life. The primary objective of this study is to assess whether voluntary quadriceps activation on the injured side is facilitated by the concomitant application of neuromuscular electrical stimulation (NMES) on the contralateral quadriceps.

Read the detailed description

The primary objective of this study is to assess whether injured-side voluntary quadriceps activation before and after ACL surgery is facilitated by the concomitant application of NMES on the contralateral quadriceps (uninjured side), in comparison to a control (CTRL) condition that does not involve any contralateral activity (passive rest) and to a voluntary (VOL) condition that involves a maximal voluntary contraction of the contralateral quadriceps.

02

Conditions studied

  • ACL Injury
03

In context

Anterior Cruciate Ligament Injuries

625 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 192 are open to participants now.

This study's planned enrollment of 25 is below the median of 56 across 458 interventional studies indexed under Anterior Cruciate Ligament Injuries.

Browse Anterior Cruciate Ligament Injuries studies →

Lead sponsor

Schulthess Klinik is the lead sponsor of 53 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing ACL surgery with semitendinosus tendon autograft in the Schulthess Clinic
  • Unilateral and primary ACL injury (with/without diagnoses of additional meniscus injury)

Exclusion criteria

Exclusion Criteria:

  • Previous surgery/ligament rupture in injured or uninjured knee or hip
  • Severe pain in the uninjured-side quadriceps or knee joint
  • Ongoing pregnancy
  • >30 kg/m²
  • Neuromuscular disease
  • Open wounds or tissue injuries on the anterior aspect of the thigh
  • Additional rupture of other knee ligaments (posterior cruciate ligament, medial collateral ligament, lateral collateral ligament)
  • Implanted metallic/electronic devices (cardiac pacemakers, defibrillators)
  • Patients getting a femoralis block (peripheral nerve block) after surgery will be excluded for the post-surgical appointment
  • Insufficient language comprehension
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Contralateral NMES

    Participants receive neuromuscular electrical stimulation (NMES) applied to the quadriceps muscle of the contralateral leg while performing voluntary quadriceps contractions on the injured side. Each participant completes two sessions: one after ACL injury and one after ACL reconstruction surgery.

    Device: Neuromuscular Electrical Stimulation

Interventions

  • DeviceNeuromuscular Electrical Stimulation

    Studies in healthy individuals have demonstrated that NMES applied to the quadriceps of one limb induces short-term increases in strength and neural drive in the contralateral homologous muscle. Since these effects have only been observed in healthy individuals, it is essential to investigate whether similar responses occur in ACL patients.

06

What researchers measure

Primary outcomes

  1. EMG activity

    EMG data will be recorded from the vastus medialis, vastus lateralis and rectus femoris muscles.

    Time frame: Data will be collected at two time points: after ACL injury (within two weeks prior to surgery) and following ACL reconstruction (within three days post-surgery).

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07156734
Lead sponsor
Schulthess Klinik
Responsible party
Nicola Maffiuletti (Head Research Group Human Performance Lab, Schulthess Klinik) — Principal investigator
First posted
Sep 5, 2025
Start date
Sep 2025 (estimated)
Primary completion
May 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Sep 5, 2025

Study contacts

Nicola Angelo Maffiuletti, PhD
Contact
nicola.maffiuletti@kws.ch
+41 44 385 75 79

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion